Advancing the applications of liquid biopsies in oncology
Top Cited Papers
- 29 May 2026
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 27 (9) , 724-738
Abstract
Liquid biopsies are increasingly important tools for precision oncology. Although their ability to detect the minute amounts of cancer biomarkers present in biofluids is improving, limitations remain regarding accurate detection of certain pathologies, analytical validation, application range and broad clinical utility. Emerging methods harness multi-omic data from a range of circulating analytes that can be released from various sources via distinct biological processes, thereby providing complementary and more sensitive information. Modulating the cellular release of these analytes and their half-lives in blood can be exploited to inform on cancer detection, treatment selection, response and/or toxicity. Simultaneously, efforts to miniaturize liquid biopsies to capitalize on their minimally invasive nature will accelerate turnaround time and enable continuous and ideally remote monitoring of circulating analytes. Together, these advances towards next-generation liquid biopsies will substantially improve patient experience.Keywords
This publication has 188 references indexed in Scilit:
- Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose OsimertinibTargeted Oncology, 2025
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: Implications for Diagnosis, Prognosis, and Therapeutic Options: Five Years of ProgressAmerican Journal of Ophthalmology, 2023
- Integrating extracellular vesicle and circulating cell‐free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patientsJournal of Extracellular Biology, 2023
- Methods for the purification and detection of single nucleotide KRAS mutations on extrachromosomal circular DNA in human plasmaCancer Medicine, 2023
- DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self‐samples and cervical scrapesInternational Journal of Cancer, 2023
- Polyadenylation ligation‐mediated sequencing (PALM‐Seq) characterizes cell‐free coding and non‐coding RNAs in human biofluidsClinical and Translational Medicine, 2022
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of Oncology, 2020
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerJAMA Oncology, 2019
- Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) ConsortiumClinical Pharmacology & Therapeutics, 2017